IRIS - Res&Arch Institutional Research Information System - Research & Archive

DILETTI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 852
EU - Europa 809
AS - Asia 252
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.916
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 850
IE - Irlanda 277
IT - Italia 217
VN - Vietnam 167
SE - Svezia 127
FI - Finlandia 67
SG - Singapore 66
RU - Federazione Russa 52
UA - Ucraina 15
DE - Germania 12
CH - Svizzera 10
HK - Hong Kong 10
FR - Francia 9
GB - Regno Unito 7
AT - Austria 4
GR - Grecia 4
CN - Cina 3
CZ - Repubblica Ceca 3
CA - Canada 2
EU - Europa 2
LB - Libano 2
NL - Olanda 2
PL - Polonia 2
TR - Turchia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
NZ - Nuova Zelanda 1
Totale 1.916
Salva come PNG Salva come JPEG
Città #
Dublin 276
Dong Ket 167
Perugia 142
Chandler 131
San Mateo 109
Boardman 68
Santa Clara 58
Lawrence 57
Medford 57
Princeton 57
Andover 46
Singapore 41
Wilmington 36
Altamura 34
San Paolo di Civitate 21
Saint Petersburg 16
Ann Arbor 13
Helsinki 10
Hong Kong 10
Norwalk 9
Rome 9
Narni 5
Moscow 3
Den Haag 2
Foligno 2
Izmir 2
Lausanne 2
Munich 2
Phoenix 2
Shanghai 2
Beijing 1
Frankfurt Am Main 1
Jacksonville 1
Limerick 1
London 1
Los Angeles 1
Montreal 1
Queenstown 1
Redmond 1
Redwood City 1
Terni 1
Volano 1
Totale 1.401
Salva come PNG Salva come JPEG
Nome #
1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials. 141
Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model. 71
Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study. 66
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm. 64
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. 55
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials. 51
Effectiveness of a novel biodegradable polymer, sirolimus-eluting stent platform in percutaneous coronary intervention 48
Operator exposure to x-ray in left and right radial access during percutaneous coronary procedures: OPERA randomised study 46
Comparison of plaque prolapse in consecutive patients treated with Xience V and Taxus Liberte stents. 45
Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. 42
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. 41
In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography. 40
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study. 39
In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis. 38
Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT. 38
Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold. 36
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. 36
Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial. 36
Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial. 36
Bioresorbable scaffolds in the treatment of coronary artery disease. 35
Short- and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns. 35
Intimal Flaps Detected by Optical Frequency Domain Imaging in the Proximal Segments of Native Coronary Arteries. 34
Morphology of coronary artery lesions assessed by virtual histology intravascular ultrasound tissue characterization and fractional flow reserve. 34
Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. 34
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. 34
Three-dimensional optical coherence tomography for guidance of complex percutaneous coronary interventions. 33
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. 33
Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies. 31
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials. 30
CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success. 30
Progress in treatment by percutaneous coronary intervention: the stent of the future. 29
Early detection and invasive passivation of future culprit lesions: a future potential or an unrealistic pursuit of chimeras? 29
Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score. 29
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. 29
Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. 28
The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. 27
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. 27
Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial. 27
ST-elevation during surgery in a young male: who would bet on inverted takotsubo syndrome? 27
Left radial versus right radial approach for coronary artery catheterization: a prospective comparison. 25
Intimal flaps detected by optical frequency domain imaging in the proximal segments of native coronary arteries: an innocent bystander? Insights from the TROFI Trial. 25
Serial 2- and 3-dimensional visualization of side branch jailing after metallic stent implantation: to kiss or not to kiss...? 25
Healing of a coronary artery dissection detected by intravascular ultrasound and optical coherence tomography. 25
Thrombus aspiration during myocardial infarction. 24
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial. 23
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery). 23
From first to second generation drug eluting stents for treatment of coronary bifurcations: are we making progress? 23
NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography. 23
Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial. 23
Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT). 22
In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis. 21
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography. 21
Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions. 20
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. 20
First observation of acute coronary syndrome triggered by calcified nodules. Angiographic and optical coherence assessment. 19
Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold. 19
Tools & techniques: risk stratification and diagnostic tools in left main stem intervention. 18
Totale 1.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 2 2 3 0 0
2020/2021353 0 2 10 4 115 20 0 0 15 10 5 172
2021/2022395 5 62 10 22 13 0 3 169 1 1 52 57
2022/2023706 57 114 1 35 41 54 0 35 339 0 24 6
2023/2024155 14 36 20 6 4 1 8 0 2 1 14 49
2024/2025124 0 57 6 4 57 0 0 0 0 0 0 0
Totale 1.983